Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia

Obinutuzumab is used for the treatment of chronic lymphocytic leukemia. So far there are no data of using this for retreatment in patients who have received it previously. We introduced obinutuzumab for the retreatment in a chronic lymphocytic leukemia patient, who had first achieved partial remissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khurana, Sharad, Ahmed, Salman, Alegria, Victoria R, Aulakh, Sonikpreet, Ailawadhi, Meghna, Singh, Anshika, Chanan-Khan, Asher, Ailawadhi, Sikander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350017/
https://www.ncbi.nlm.nih.gov/pubmed/30728976
http://dx.doi.org/10.1177/2050313X18823917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350017/
https://www.ncbi.nlm.nih.gov/pubmed/30728976
http://dx.doi.org/10.1177/2050313X18823917

Ejemplares similares